The Gates Foundation launched the EVAH Initiative in association with Novo Nordisk and Wellcome Trust, focusing on AI-enabled clinical decision support tools. The initiative represents a collaboration between major philanthropic and pharmaceutical organizations to advance AI applications in clinical settings. This signals growing institutional investment in AI tools that could standardize and improve clinical decision-making processes across healthcare systems.